focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,096.00
Bid: 12,088.00
Ask: 12,092.00
Change: -14.00 (-0.12%)
Spread: 4.00 (0.033%)
Open: 12,090.00
High: 12,118.00
Low: 12,038.00
Prev. Close: 12,110.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-London stocks slip after glum GDP data, end with second week of gains

Fri, 10th Dec 2021 10:09

* AstraZeneca falls on price target cut

* UK economy barely grew in October

* Data raises doubts around rate hikes

* FTSE 100 off 0.4%, FTSE 250 down 0.9%
(Adds comments, updates prices throughout)

By Bansari Mayur Kamdar

Dec 10 (Reuters) - UK's FTSE 100 and mid caps indexes
slipped for a third straight session on Friday after data
pointed to stalling economic growth in Britain, even before the
emergence of the Omicron coronavirus variant, but ended their
second week in the black.

The benchmark FTSE 100 index eased 0.4% pressured by
the healthcare sector after heavyweight drugmaker
AstraZeneca fell 2.0% after Berenberg cut its price
target on the stock.

The main index clocked its biggest weekly gain in eight
months, boosted by a strong recovery in mining stocks.

"We're seeing a flight to safety with defensive names like
British American Tobacco on the front foot," said Justin
McQueen, market analyst at DailyFX.

"The sort of news around Omicron and the government
announcing its plan B and suggestions around plan C does put the
final nail in the coffin for a rate rise next week."

Data showed Britain's economy grew by a weaker-than-expected
0.1% in October, leaving it 0.5% smaller than it was in February
2020, just before the country went into its first COVID-19
lockdown.

"The big drop in people visiting pubs, bars and restaurants
doesn't bode well for the idea that we're all rediscovering our
freedom post-lockdown. Perhaps this catalyst has now played out
and people are yearning for the warmth of their home during the
autumn and winter instead," said Russ Mould, investment director
at AJ Bell.

The domestically focussed mid-cap index fell 0.9%,
after Ashmore Group dropped 2.7% as Goldman Sachs
downgraded the asset manager to "neutral".

The numbers further raised doubts about a December rate hike
after Prime Minister Boris Johnson this week announced new
coronavirus guidelines ordering people to work from home, wear
masks in public places and use vaccine passes for bit public
events.

Capping losses on the main index, miners
gained 0.7% tracking copper prices, and defensive stocks such as
consumer staples, which tend to be less sensitive to the
economic climate, also rose.

British American Tobacco gained nearly 2.5% after a
Wall Street Journal report that said the U.S. Senate was
dropping a proposal to impose higher taxes on vaping, oral
nicotine and other NGPs.
(Reporting by Bansari Mayur Kamdar in Bengaluru
Editing by Subhranshu Sahu, Amy Caren Daniel and Frances Kerry)

More News
8 Jan 2024 14:08

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
6 Jan 2024 17:44

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
5 Jan 2024 12:00

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 08:04

C4X receives USD11 million from AstraZeneca following NRF2 trials

(Alliance News) - C4X Discovery Holdings PLC on Wednesday said it has received payment from AstraZeneca PLC following trials of the C4X respiratory disease therapy treatment.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
2 Jan 2024 17:05

British equities slip on higher yields, financials drag

FTSE 100 down 0.2%, FTSE 250 off 0.9%

*

Read more
2 Jan 2024 12:01

LONDON MARKET MIDDAY: London stocks make largely soft start to 2024

(Alliance News) - Stock prices in London were mostly lower at midday on Tuesday in a slow start to the new year, reacting to the UK manufacturing sector finishing a tricky 2023 with a further contraction in December.

Read more
2 Jan 2024 11:00

Weight-loss drugs: Who, and what, are they good for?

Jan 2 (Reuters) - Powerful weight-loss medicines like Novo Nordisk's Wegovy leapt into public view in 2023, from social media to doctors' offices and cocktail parties, offering a new way to address record obesity rates.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.